BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15369775)

  • 1. Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets.
    Klein D; Ribeiro MM; Mendoza V; Jayaraman S; Kenyon NS; Pileggi A; Molano RD; Inverardi L; Ricordi C; Pastori RL
    Biochem Biophys Res Commun; 2004 Oct; 323(2):473-8. PubMed ID: 15369775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
    Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
    Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.
    Stevens M; Oltean S
    Front Genet; 2019; 10():804. PubMed ID: 31552099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology in cell replacement therapies for type 1 diabetes.
    Ernst AU; Bowers DT; Wang LH; Shariati K; Plesser MD; Brown NK; Mehrabyan T; Ma M
    Adv Drug Deliv Rev; 2019 Jan; 139():116-138. PubMed ID: 30716349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis.
    Vervliet T; Gerasimenko JV; Ferdek PE; Jakubowska MA; Petersen OH; Gerasimenko OV; Bultynck G
    Cell Death Discov; 2018; 4():58. PubMed ID: 29760956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered cell sheet composed of human islets and human fibroblast, bone marrow-derived mesenchymal stem cells, or adipose-derived mesenchymal stem cells: An in vitro comparison study.
    Imamura H; Adachi T; Kin T; Ono S; Sakai Y; Adachi T; Soyama A; Hidaka M; Takatsuki M; Shapiro AMJ; Eguchi S
    Islets; 2018 May; 10(3):e1445948. PubMed ID: 29608395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.
    Kollek M; Voigt G; Molnar C; Murad F; Bertele D; Krombholz CF; Bohler S; Labi V; Schiller S; Kunze M; Geley S; Niemeyer CM; Garcia-Saez A; Erlacher M
    J Exp Med; 2017 Oct; 214(10):2967-2983. PubMed ID: 28882984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-independent phospholipases A2 and their roles in biological processes and diseases.
    Ramanadham S; Ali T; Ashley JW; Bone RN; Hancock WD; Lei X
    J Lipid Res; 2015 Sep; 56(9):1643-68. PubMed ID: 26023050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model.
    Hwang HS; Park IY; Kim DW; Choi SY; Jung YO; Kim HA
    BMB Rep; 2015 Jul; 48(7):407-12. PubMed ID: 25887750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain.
    Vervliet T; Lemmens I; Vandermarliere E; Decrock E; Ivanova H; Monaco G; Sorrentino V; Nadif Kasri N; Missiaen L; Martens L; De Smedt H; Leybaert L; Parys JB; Tavernier J; Bultynck G
    Sci Rep; 2015 Apr; 5():9641. PubMed ID: 25872771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.
    Barbour SE; Nguyen PT; Park M; Emani B; Lei X; Kambalapalli M; Shultz JC; Wijesinghe D; Chalfant CE; Ramanadham S
    J Biol Chem; 2015 Apr; 290(17):11021-31. PubMed ID: 25762722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
    Vargas N; Álvarez-Cubela S; Giraldo JA; Nieto M; Fort NM; Cechin S; García E; Espino-Grosso P; Fraker CA; Ricordi C; Inverardi L; Pastori RL; Domínguez-Bendala J
    PLoS One; 2011; 6(8):e22364. PubMed ID: 21857924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation and encapsulation: an update on recent developments.
    Vaithilingam V; Tuch BE
    Rev Diabet Stud; 2011; 8(1):51-67. PubMed ID: 21720673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury.
    Iwata A; Morgan-Stevenson V; Schwartz B; Liu L; Tupper J; Zhu X; Harlan J; Winn R
    PLoS One; 2010 Feb; 5(2):e9103. PubMed ID: 20161703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells.
    Grunnet LG; Aikin R; Tonnesen MF; Paraskevas S; Blaabjerg L; Størling J; Rosenberg L; Billestrup N; Maysinger D; Mandrup-Poulsen T
    Diabetes; 2009 Aug; 58(8):1807-15. PubMed ID: 19470609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-apoptotic peptide improves survival in lethal total body irradiation.
    McDunn JE; Muenzer JT; Dunne B; Zhou A; Yuan K; Hoekzema A; Hilliard C; Chang KC; Davis CG; McDonough J; Hunt C; Grigsby P; Piwnica-Worms D; Hotchkiss RS
    Biochem Biophys Res Commun; 2009 May; 382(4):657-62. PubMed ID: 19303399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
    Rong YP; Barr P; Yee VC; Distelhorst CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):971-8. PubMed ID: 19056433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental effects of antiapoptotic treatments in spinal cord injury.
    Cittelly DM; Nesic O; Johnson K; Hulsebosch C; Perez-Polo JR
    Exp Neurol; 2008 Apr; 210(2):295-307. PubMed ID: 18302959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.
    Ju KL; Manley NC; Sapolsky RM
    Exp Neurol; 2008 Apr; 210(2):602-7. PubMed ID: 18207142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
    Fornoni A; Pileggi A; Molano RD; Sanabria NY; Tejada T; Gonzalez-Quintana J; Ichii H; Inverardi L; Ricordi C; Pastori RL
    Diabetologia; 2008 Feb; 51(2):298-308. PubMed ID: 18066521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.